Quantcast

Latest cell therapy Stories

2014-06-03 23:02:06

On June 3, at the 7th Annual Massachusetts Life Sciences Innovation Day, Dr. James L. Sherley, Director of The Adult Stem Cell Technology Center, LLC presented a new technology developed to identify drug candidates that are toxic to adult stem cells. This first technology of its kind meets a long-standing unmet need of the pharmaceutical industry, with potential to save billions of dollars in drug development costs each year while accelerating the arrival of new effective, and safe, drugs...

2014-06-03 12:38:22

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biobanking for Medicine: Technology, Industry and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare/biotechnology/biobanking_medicine_technology_market.html Report DetailsBiobanks - how to find business trends, R&D, and revenue forecastsWhat does the future hold for medical biobanks? Now you get technological and commercial predictions from 2014. Stay ahead, then, for data,...

2014-06-03 12:37:18

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024http://www.reportbuyer.com/pharma_healthcare/research_r_d/translational_regenerative_medicine_market_prospects_2012_2022.html Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to...

2014-05-30 23:08:15

MetroMD DOT Therapy now brings in a chance to alleviate individuals from all these problems. Persons with scars resulting from acne or other skin conditions and injuries can also benefit from this procedure. Los Angeles, CA (PRWEB) May 30, 2014 MetroMD Institute of Regenerative Medicine, a clinic that specializes in HGH and stem cell therapy, introduces an advanced cosmetic regeneration therapy that makes use of CO2 Fractional Laser System and highly efficient DOT to cure age-related skin...

2014-05-30 08:25:21

SANTA MONICA, Calif., May 30, 2014 /PRNewswire/ -- Kite Pharma, Inc. (Kite), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for the treatment of cancer, today announced the Company will provide details on key features of the rapid, 6-day manufacturing process that is expected to underlie its most advanced personalized cancer immunotherapy program. The technology is expected to underpin a Kite clinical trial in...

2014-05-29 08:30:21

SAN DIEGO, May 29, 2014 /PRNewswire/ -- ViaCyte, Inc., a regenerative medicine company focused on developing a cell replacement therapy for the treatment of patients with insulin-dependent diabetes, announced today that the Company has settled a patent dispute involving certain of the Company's definitive endoderm patents and patent applications. The dispute involved an appeal to the U.S. District Court by Asterias Biotherapeutics, Inc., (as assignee of Geron Corporation), which...

2014-05-27 16:25:18

NEW YORK, May 27, 2014 /PRNewswire/ -- Brian Mehling, M.D., an American orthopedic trauma surgeon, founder, and chief medical officer of Blue Horizon International (BHI) and Blue Horizon Charitable Foundation (BHCF), visited with orphaned children on a recent business trip to Abuja and Lagos in Nigeria. After touring the facility, meeting with the founder, and her staff, he also made a $1,000 donation to help the orphanage fulfill its vision to provide shelter for abandoned and...

2014-05-27 12:33:02

Americord Yields 60% More CD34+ Stem Cells, 54% More Cord Blood, and 34% Higher TNC Than Competitors NEW YORK, May 27, 2014 /PRNewswire/ -- Americord announced today that its cord blood stem cell collection statistics beat the cord blood banking industry averages by significant margins across three critical measures. An in-depth analysis of collection samples through March 31, 2014 revealed that Americord collects 60% more CD34+ stem cells, 54% higher volume, and 34% higher total...

2014-05-27 08:28:00

SB-728-T-Treated Subject Maintains Control of Viral Load for 45 Weeks Without Anti-Retroviral Drugs RICHMOND, Calif., May 27, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics(®) were outlined in several presentations and posters at the 17th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) from May 21-24, 2014....

2014-05-26 23:02:26

A number of factors such as increasing funding from various government and private organizations, growing industry focus on stem cell research, and rising global awareness about stem cell therapies through various organizations are driving the growth of the global market (http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html). (PRWEB) May 26, 2014 The report “Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related